Characterisation of CDKL5 Transcript Isoforms in Human and Mouse

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jun 18

PMID 27315173

Citations 37

Authors

Ralph D Hector

Owen Dando

Nicoletta Landsberger

Charlotte Kilstrup-Nielsen

Peter C Kind

Mark E S Bailey

Stuart R Cobb

Affiliations

Soon will be listed here.

Abstract

Mutations in the X-linked Cyclin-Dependent Kinase-Like 5 gene (CDKL5) cause early onset infantile spasms and subsequent severe developmental delay in affected children. Deleterious mutations have been reported to occur throughout the CDKL5 coding region. Several studies point to a complex CDKL5 gene structure in terms of exon usage and transcript expression. Improvements in molecular diagnosis and more extensive research into the neurobiology of CDKL5 and pathophysiology of CDKL5 disorders necessitate an updated analysis of the gene. In this study, we have analysed human and mouse CDKL5 transcript patterns both bioinformatically and experimentally. We have characterised the predominant brain isoform of CDKL5, a 9.7 kb transcript comprised of 18 exons with a large 6.6 kb 3'-untranslated region (UTR), which we name hCDKL5_1. In addition we describe new exonic regions and a range of novel splice and UTR isoforms. This has enabled the description of an updated gene model in both species and a standardised nomenclature system for CDKL5 transcripts. Profiling revealed tissue- and brain development stage-specific differences in expression between transcript isoforms. These findings provide an essential backdrop for the diagnosis of CDKL5-related disorders, for investigations into the basic biology of this gene and its protein products, and for the rational design of gene-based and molecular therapies for these disorders.

Citing Articles

A Novel Mouse Model Unveils Protein Deficiency in Truncated CDKL5 Mutations.

Feng X, Zhu Z, Wang H, Zhou H, Liu J, Shen Y Neurosci Bull. 2025; .

PMID: 40042769 DOI: 10.1007/s12264-024-01346-4.

Engineered tRNAs efficiently suppress CDKL5 premature termination codons.

Pezzini S, Mustaccia A, Aboa P, Faustini G, Branchini A, Pinotti M Sci Rep. 2024; 14(1):31791.

PMID: 39738338 PMC: 11685654. DOI: 10.1038/s41598-024-82766-0.

A new knockin mouse carrying the E364X patient mutation for CDKL5 deficiency disorder: neurological, behavioral and molecular profiling.

Quadalti C, Sannia M, Humphreys N, Baldassarro V, Gurgone A, Ascolani M Heliyon. 2024; 10(21):e40165.

PMID: 39583831 PMC: 11584566. DOI: 10.1016/j.heliyon.2024.e40165.

Deletions in the CDKL5 5' untranslated region lead to CDKL5 deficiency disorder.

Haviland I, Hector R, Swanson L, Verran A, Sherrill E, Frazier Z Am J Med Genet A. 2024; 197(1):e63843.

PMID: 39205479 PMC: 11637933. DOI: 10.1002/ajmg.a.63843.

Bacterial Production of CDKL5 Catalytic Domain: Insights in Aggregation, Internal Translation and Phosphorylation Patterns.

Colarusso A, Lauro C, Cane L, Cozzolino F, Tutino M Int J Mol Sci. 2024; 25(16).

PMID: 39201578 PMC: 11354467. DOI: 10.3390/ijms25168891.

References

Diebold B, Delepine C, Gataullina S, Delahaye A, Nectoux J, Bienvenu T . Mutations in the C-terminus of CDKL5: proceed with caution. Eur J Hum Genet. 2013; 22(2):270-2. PMC: 3895649. DOI: 10.1038/ejhg.2013.133. View

Fichou Y, Nectoux J, Bahi-Buisson N, Chelly J, Bienvenu T . An isoform of the severe encephalopathy-related CDKL5 gene, including a novel exon with extremely high sequence conservation, is specifically expressed in brain. J Hum Genet. 2010; 56(1):52-7. DOI: 10.1038/jhg.2010.143. View

Nemos C, Lambert L, Giuliano F, Doray B, Roubertie A, Goldenberg A . Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature. Clin Genet. 2009; 76(4):357-71. DOI: 10.1111/j.1399-0004.2009.01194.x. View

Rademacher N, Hambrock M, Fischer U, Moser B, Ceulemans B, Lieb W . Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features. Neurogenetics. 2011; 12(2):165-7. DOI: 10.1007/s10048-011-0277-6. View

Intusoma U, Hayeeduereh F, Plong-On O, Sripo T, Vasiknanonte P, Janjindamai S . Mutation screening of the CDKL5 gene in cryptogenic infantile intractable epilepsy and review of clinical sensitivity. Eur J Paediatr Neurol. 2011; 15(5):432-8. DOI: 10.1016/j.ejpn.2011.01.005. View

McMahon A, Barnett M, OLeary T, Stoney P, Collins M, Papadia S . SynGAP isoforms exert opposing effects on synaptic strength. Nat Commun. 2012; 3:900. PMC: 3621422. DOI: 10.1038/ncomms1900. View

Fehr S, Wilson M, Downs J, Williams S, Murgia A, Sartori S . The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur J Hum Genet. 2012; 21(3):266-73. PMC: 3573195. DOI: 10.1038/ejhg.2012.156. View

Rusconi L, Salvatoni L, Giudici L, Bertani I, Kilstrup-Nielsen C, Broccoli V . CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem. 2008; 283(44):30101-11. PMC: 2662074. DOI: 10.1074/jbc.M804613200. View

Pecorelli A, Belmonte G, Meloni I, Cervellati F, Gardi C, Sticozzi C . Alteration of serum lipid profile, SRB1 loss, and impaired Nrf2 activation in CDKL5 disorder. Free Radic Biol Med. 2015; 86:156-65. PMC: 5572621. DOI: 10.1016/j.freeradbiomed.2015.05.010. View

10.

Lister R, Mukamel E, Nery J, Urich M, Puddifoot C, Johnson N . Global epigenomic reconfiguration during mammalian brain development. Science. 2013; 341(6146):1237905. PMC: 3785061. DOI: 10.1126/science.1237905. View

11.

Kilstrup-Nielsen C, Rusconi L, La Montanara P, Ciceri D, Bergo A, Bedogni F . What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Neural Plast. 2012; 2012:728267. PMC: 3385648. DOI: 10.1155/2012/728267. View

12.

Fehr S, Leonard H, Ho G, Williams S, de Klerk N, Forbes D . There is variability in the attainment of developmental milestones in the CDKL5 disorder. J Neurodev Disord. 2015; 7(1):2. PMC: 4318547. DOI: 10.1186/1866-1955-7-2. View

13.

Zhu Y, Li D, Wang L, Lu B, Zheng J, Zhao S . Palmitoylation-dependent CDKL5-PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development. Proc Natl Acad Sci U S A. 2013; 110(22):9118-23. PMC: 3670390. DOI: 10.1073/pnas.1300003110. View

14.

Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

15.

Thorvaldsdottir H, Robinson J, Mesirov J . Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2012; 14(2):178-92. PMC: 3603213. DOI: 10.1093/bib/bbs017. View

16.

Yamashita R, Sugano S, Suzuki Y, Nakai K . DBTSS: DataBase of Transcriptional Start Sites progress report in 2012. Nucleic Acids Res. 2011; 40(Database issue):D150-4. PMC: 3245115. DOI: 10.1093/nar/gkr1005. View

17.

Hanks S, Hunter T . Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995; 9(8):576-96. View

18.

Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M . Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet. 2004; 75(6):1149-54. PMC: 1182152. DOI: 10.1086/426460. View

19.

Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R . Fast and effective prediction of microRNA/target duplexes. RNA. 2004; 10(10):1507-17. PMC: 1370637. DOI: 10.1261/rna.5248604. View

20.

Artuso R, Mencarelli M, Polli R, Sartori S, Ariani F, Pollazzon M . Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev. 2009; 32(1):17-24. DOI: 10.1016/j.braindev.2009.02.004. View